One needle, two drugs: could a combo shot simplify weight loss?
NCT ID NCT04940078
First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 27 times
Summary
This study looked at whether two weight-loss medications, cagrilintide and semaglutide, can be given together in one injection instead of two separate shots. Forty adults with overweight or obesity took part. The main goal was to measure how much of each drug gets into the blood with each method. This was a Phase 1 study focused on drug levels, not on weight loss itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Altasciences Company Inc.
Montreal, Quebec, H3P 3P1, Canada
-
Novo Nordisk Investigational Site
Søborg, 2860, Denmark
Conditions
Explore the condition pages connected to this study.